DFDA

Hydrochlorothiazide + Low Sodium Diet

Treatment for Menieres Disease

Typical Dosage: HCTZ 12.5-25mg daily, low-sodium diet (<1500mg/day)

Effectiveness
68%
Safety Score
68%
Clinical Trials
40
Participants
7.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
HCTZ 12.5-25mg daily, low-sodium diet (<1500mg/day)
Time to Effect
1-4 weeks
Treatment Duration
Lifetime
Evidence Quality
MODERATE
Confidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$450
Side Effect Mgmt:$50
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$833
Cost per Remission
$2,000
Hydrochlorothiazide + Low Sodium Diet Outcomes

for Menieres Disease

Efficacy Outcomes
Overall Effectiveness
+68%
Response Rate
+60%
Remission Rate
+25%
Common Side Effects
Dizziness
+8%
Fatigue
+7%
Hypokalemia
+12%
Increased urination
+25%

Sources:

hearinghealthmatters.org
nih.gov
droracle.ai

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov